Refine your search

Clear

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Fragile X Syndrome - RECONNECT

The purpose of this study is to investigate how effective and safe ZYN002, a transdermal gel, is in patients with FXS in managing behavioral symptoms.
Patricia Gordon at pgordon@pennstatehealth.psu.edu
All
Younger than 18 years old
This study is NOT accepting healthy volunteers
NCT04977986
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Diagnosis of Fragile X Syndrome
Ages 3-17
ABC-C FXS Social Avoidance Score </= 5
Exclusion Criteria:
Use of THC or CBD containing products within 3 months of screening
Females who are pregnant, nursing, or planning a pregnancy
Mental & Behavioral Health, Children's Health
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA